Atlas Trials

Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL)

Clinical trial NCT00927797 · UNKNOWN

Trial details

NCT number
NCT00927797
Sponsor
Heidelberg University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Immunocytoma/Morbus WaldenströmB-Cell Non-Hodgkin's LymphomaB-Cell Chronic Lymphocytic Leukemia
Start date
2005-02-01
Primary completion
2009-01-01
Enrollment
185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.